rs381427
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PP2PP3PP5_Moderate
The NM_000157.4(GBA1):c.689T>G(p.Val230Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000558 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V230A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000157.4 missense
Scores
Clinical Significance
Conservation
Publications
- Parkinson diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Gaucher diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Gaucher disease perinatal lethalInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- late-onset Parkinson diseaseInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Gaucher disease type IInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- Gaucher disease type IIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Gaucher disease type IIIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GBA1 | NM_000157.4 | c.689T>G | p.Val230Gly | missense_variant | Exon 6 of 11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151988Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251390 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461844Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727216 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151988Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74230 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Gaucher disease Pathogenic:1
Variant summary: GBA1 c.689T>G (p.Val230Gly) results in a non-conservative amino acid change located in the TIM-barrel domain (IPR033453) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-06 in 1606838 control chromosomes in the gnomAD database (v4.0 dataset), however the variant is located in a region that is known to be highly homologous to the GBA pseudogene, therefore these data might not be reliable. The variant, c.689T>G, has been reported in the literature in compound heterozygote individuals affected with Gaucher Disease (e.g. Choy_1997, Giraldo_2011, Narita_2014, Huang_2020, Kim_2020), and multiple publications noted that the diagnosis of Gaucher disease was confirmed biochemically, demonstrating <5% of normal glucocerebrosidase activity in patients samples (e.g. Choy 1997, Huang_2020). These data indicate that the variant is very likely to be associated with disease. The variant was also reported as a complex allele, together with several pathogenic variants in cis, in multiple compound heterozygous individuals affected with Gaucher Disease, and in heterozygotes affected with early onset Parkinson disease (e.g. Du_2018, Kang_2018, Olkhovych_2017 [NO_PMID], Sheth_2019, D Amore_2021, Ren_2023), where the complex alleles encompassing several variants are believed to be the result of recombination events with the highly homologous pseudogene (see e.g. Hruska_2008). The following publications have been ascertained in the context of this evaluation (PMID: 18338393, 10206680, 19433657, 34649574, 30461613, 32165122, 29934114, 33176831, 25356393, 30764785, 36845659, 22429443). ClinVar contains an entry for this variant (Variation ID: 928835). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at